Anti-Helicobacter pylori agents.: 4.: 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives

被引:20
作者
Katsura, Y
Tomishi, T
Inoue, Y
Sakane, K
Matsumoto, Y
Morinaga, C
Ishikawa, H
Takasugi, H
机构
[1] Fujisawa Pharmaceut Co Ltd, Res Planning Res Div, Med Chem Res Labs, Yodogawa Ku, Osaka 5328514, Japan
[2] Fujisawa Pharmaceut Co Ltd, Res Planning Res Div, Med Biol Res Labs, Yodogawa Ku, Osaka 5328514, Japan
关键词
D O I
10.1021/jm000169n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In order to find a new class of anti-Helicobacter pylori (H. pylori) agents, a series of 4-[(3-acetamido)phenyl]-2-(substituted guanidino)thiazoles and some structurally rigid analoges were synthesized and evaluated for antimicrobial activity against H. pylori. Among the compounds obtained, high anti-H. pylori activities were observed in benzyl derivative 34 (MIC = 0.025 mu g/mL) and phenethyl derivatives 35 and 36 (MIC = 0.037 mu g/mL and 0.017 mu g/mL). Though alkyl derivatives generally showed lower activity, the 2-methoxyethyl derivative 28 preserved significant activity (MIC = 0.32 mu g/mL) and also exhibited more potent gastric antisecretory activity than ranitidine. Structural restriction by bridging between the thiazole and the phenyl rings with an alkyl chain did not improve the activity in this series.
引用
收藏
页码:3315 / 3321
页数:7
相关论文
共 27 条
[1]   ULCERS AS AN INFECTIOUS-DISEASE [J].
ALPER, J .
SCIENCE, 1993, 260 (5105) :159-160
[2]  
ATESHKADI A, 1993, CLIN PHARMACY, V12, P34
[3]   Eradication of Helicobacter pylori [J].
Axon, ATR .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 :47-53
[4]   Helicobacter pylori and peptic ulcer disease [J].
Blum, AL .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 :24-27
[5]   CONFORMATIONAL AND STERIC MODIFICATIONS OF THE PYRAN RING OF THE POTASSIUM-CHANNEL ACTIVATOR CROMAKALIM [J].
BUCKLE, DR ;
EGGLESTON, DS ;
HOUGEFRYDRYCH, CSV ;
PINTO, IL ;
READSHAW, SA ;
SMITH, DG ;
WEBSTER, RAB .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1991, (11) :2763-2771
[6]  
CHIBA N, 1992, AM J GASTROENTEROL, V87, P1716
[7]  
DOOLEY CP, 1991, ALIMENT PHARM THERAP, V5, P129
[8]   Helicobacter pylori [J].
Dunn, BE ;
Cohen, H ;
Blaser, MJ .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :720-+
[9]   THE ROLE AND TREATMENT OF HELICOBACTER-PYLORI INFECTION IN PEPTIC-ULCER DISEASE - A REVIEW OF THE RELATIONSHIP BETWEEN HELICOBACTER-PYLORI INFECTION AND PEPTIC-ULCER DISEASE [J].
FLETCHER, PJ ;
CRAIG, DQM .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1993, 18 (05) :311-316
[10]  
GLUPCZYNSKI Y, 1990, AM J GASTROENTEROL, V85, P1545